311 papers
Immunology explores the intricate defense systems that keep our bodies safe from infections and disease. This field examines how our immune cells recognize threats, coordinate responses, and maintain a delicate balance between fighting invaders and avoiding self-harm. From understanding vaccine mechanisms to investigating autoimmune disorders, these studies reveal the dynamic biology protecting human health every day.
On Gist.Science, we ensure these critical discoveries remain accessible to everyone. We automatically process every new preprint in this category as it appears on bioRxiv, transforming complex research into both plain-language explanations and detailed technical summaries. This approach allows readers to grasp the core findings without getting lost in dense jargon, while still providing the depth needed for scientific inquiry.
Below are the latest immunology papers from bioRxiv, each accompanied by our curated summaries to help you navigate the newest breakthroughs in the field.
This study identifies B7-H4 as a site-specific, highly upregulated immune checkpoint in small bowel gastrointestinal stromal tumors (GISTs) that drives an immunosuppressive microenvironment, distinguishing them from gastric GISTs and highlighting B7-H4 as a promising therapeutic target for this aggressive subtype.
This study demonstrates that virus-like mesoporous silica nanoparticles with tunable rigid nanospikes mechanically activate Piezo1 to drive Ca2+ influx, which synergizes with STING signaling and cancer cell membrane antigens to robustly reprogram macrophages into the anti-tumor M1 phenotype in a spike-length-dependent manner.
This study demonstrates that medical-grade Manuka honey and its sugar-free extract inhibit Substance P-induced mast cell degranulation by suppressing MRGPRX2 expression, a mechanism supported by findings of elevated MRGPRX2 levels in Interstitial Cystitis/Bladder Pain Syndrome patients, suggesting these natural preparations as promising therapeutic agents for managing neurogenic bladder inflammation.
This study demonstrates that targeting myeloid cells in glioblastoma with ABCA1 siRNA-loaded lipid nanoparticles reprograms cholesterol metabolism to enhance antigen presentation and unleash anti-tumor immunity, effectively overcoming therapy resistance in immunologically cold tumors.
This study demonstrates that personalized neoantigen vaccines synergize with immune checkpoint inhibitors and CD8-targeted cytokines to overcome T-cell dysfunction and achieve durable systemic elimination of B-cell lymphoma in both local and disseminated murine models.
This study demonstrates that in a mouse model of type 1 diabetes, the loss of SAP protein protects against disease by suppressing pro-inflammatory anti-insulin B cell activation and subsequent CD8+ T cell-mediated islet destruction, while notably preserving T follicular helper cell responses and extrafollicular antibody immunity.
This study demonstrates that the LiteVax adjuvant enhances influenza vaccine immunogenicity in older adults by inducing a transient interferon-driven innate response that accelerates early IgG3 production and improves T-cell memory differentiation, thereby mitigating age-related immune decline.
This study demonstrates that engineering T cell receptors to form force-induced catch bonds, rather than pursuing high-affinity maturation, significantly enhances sensitivity and therapeutic efficacy against solid tumors while avoiding off-target toxicities by leveraging mechanosensory properties to improve antigen recognition and signaling.
This study reveals that Gelsolin acts as a critical safeguard against psoriasis-like dermatitis by directly binding imiquimod to mitigate ER stress-driven inflammatory circuits, which otherwise amplify IL-23 and NLRP3 signaling through ER-mitochondria contact sites and a feed-forward loop involving extracellular mtDNA and antimicrobial peptides.
This study demonstrates that a prime-and-pull vaccination strategy, combining subcutaneous BCG with mucosal mRNA delivery, effectively induces protective lung immunity against tuberculosis while maintaining the safety profile of parenteral administration.